Keyphrases
Poor Outcome
100%
Vascular Endothelial Growth Factor
100%
Distant Metastasis
100%
Tumor Metastasis
50%
Hypoxia-inducible factor-1α (HIF-1α)
50%
Primary Tumor
33%
Regional Metastasis
33%
Gene Expression Pattern
16%
Gene Expression Profile
16%
Effective Therapy
16%
Microarray
16%
Lung Cancer
16%
Outcome Prediction
16%
Immunohistochemistry
16%
Fibroblasts
16%
Glioblastoma
16%
Primary Breast Cancer
16%
Prognostic Significance
16%
Patient Survival
16%
High-level Expression
16%
Patients with Breast Cancer
16%
Binding Site
16%
Clinical Variables
16%
Tumor Subtype
16%
Cell Signaling Pathways
16%
Lymphatic Vessels
16%
Metastatic Spread
16%
New Blood Vessel
16%
Dual Targeting
16%
Vessel Formation
16%
Multiple Tumors
16%
Gene Profile
16%
Monocarboxylic Acid Transporter
16%
Biological Characteristics
16%
Prognostic Genes
16%
Primary Breast Tumor
16%
Angiopoietin-like 4 (ANGPTL4)
16%
Disseminated Tumor Cells
16%
Hypoxia Response
16%
SLC16A3
16%
Regional Lymph Node Metastasis
16%
Supervised Analysis
16%
Multiple Cell Types
16%
Hypoxia Signature
16%
Medicine and Dentistry
Vasculotropin
100%
Distant Metastasis
100%
Metastatic Carcinoma
50%
Breast Cancer
33%
Hypoxia
33%
Gene Expression
33%
Primary Tumor
33%
Regional Metastasis
33%
Cancer Cell
16%
Lung Cancer
16%
Breast Tumor
16%
Glioblastoma
16%
Lymph Node Metastasis
16%
Immunohistochemistry
16%
Angiogenesis
16%
Proteus Syndrome
16%
Disseminated Cancer
16%
Lymphangiogenesis
16%
Carboxylic Acid
16%
Binding Site
16%
Fibroblast
16%
Neuroscience
Vascular Endothelial Growth Factor
100%
Gene Expression
40%
In Vivo
20%
Binding Site
20%
Carboxylic Acid
20%
Immunohistochemistry
20%
Lymph Node
20%
Angiogenesis
20%
Lymphangiogenesis
20%
Fibroblast
20%
Biochemistry, Genetics and Molecular Biology
Vascular Endothelial Growth Factor
100%
Gene Expression
40%
ANGPTL4
20%
Cancer Cell
20%
Binding Site
20%
Angiogenesis
20%
Lymphangiogenesis
20%
Fibroblast
20%